Misty Lynn Gonzalez, Pharm.D., BCPP
Clinical Associate Professor, Pharmacy Practice
SIUE School of Pharmacy Psychiatry
Psychiatric Clinical Pharmacist
Barnes-Jewish Hospital
Phone: 314-305-6650
Email: misgonz@siue.edu
Dr. Misty Gonzalez is a clinical associate professor in the Department of Pharmacy Practice. She practices psychiatric clinical pharmacy and participates in interdisciplinary teaching rounds partnered with Barnes-Jewish Hospital and Washington University Saint Louis School of Medicine. Dr. Gonzalez joined SIUE from the New York State Office of Mental Health and the University at Buffalo, State University of New York, where she completed residencies in pharmacy practice and psychiatry. Dr. Gonzalez is a graduate of Purdue University College of Pharmacy.
Education/Training/Background:
| Board Certified Psychiatric Pharmacist, 2010, Board of Pharmacy Specialities |
| PGY-2 Psychiatric Pharmacy Practice Residency, 2009, University at Buffalo, The State University of New York, Buffalo, N.Y. |
| PGY-1 General Practice Residency, Emphasis Psychiatry, 2008, University at Buffalo, The State University of New York, Buffalo, N.Y. |
| Doctor of Pharmacy, 2007, Purdue University School of Pharmacy and Pharmaceutical Sciences, West Lafayette, Ind. |
Clinical interests:
Areas of interest include treatment of severe and persistent mental illness and comorbid medical conditions, mentally ill chemical abusers, drug-induced psychosis, and adjunctive pharmacotherapy for prevention and management of psychiatric crisis situations. Dr. Gonzalez aims to communicate the fundamentals of psychopharmacology while serving as a role model for an empathetic approach in participating in the care of individuals challenged with mental illness.
Practice Site Information
Dr. Gonzalez's current practice site is inpatient psychiatry at Barnes-Jewish Hospital in St. Louis. By integrating didactic coursework with case-based teaching, Dr. Gonzalez fosters critical thinking, facilitates the acquisition of life-long learning skills, and assists in the development of problem-solving strategies to navigate through the psychotropic-related situations pharmacists may encounter in their careers. Her clinical practice includes modeling the ideology of maintaining hope for recovery and for the reduction of stigma against individuals challenged with mental illness.
Scholarly Interests
Research interests include pharmacogenomics, treatment of chronic schizophrenia, delirium, prevention of medication side effects, and adjunctive pharmacotherapy and psychotherapy for prevention and management of psychiatric crisis situations.
Other Professional Activities
2011-Present Illinois Council of Health-System Pharmacists (ICHP)
2007-Present College of Psychiatric and Neurologic Pharmacists (CPNP)
2007-Present National Alliance on Mental Illness (NAMI)
2008-2009 Chief Resident, University at Buffalo-SUNY, Pharmacy Residency and Fellowship Program
2005-2007 American Pharmacists Association – Academy of Student Pharmacists (APhA-ASP)
Professional Presentations & Publications
Presentations
Southern Illinois University School of Medicine, Internal Medicine Grand Rounds: Optimizing Opioid Interventions and Mitigating Risk in Pain Management. Springfield, IL. January 2013.
Continuing Education Institute of Illinois: Pain and the Older Adult: Assessment, Intervention and Management. Edwardsville, IL and Springfield, IL. 2012-13.
Pediatric Pharmacy Advocacy Group (PPAG) Webinar: Incorporating Pharmacogenomics into Clinical Pharmacy Practice: Focus on Psychiatry. Live national webcast. July 2012.
Southern Illinois University School of Medicine, Family Medicine Grand Rounds: Neurology and Psychiatric Meds. Springfield, IL. May 2012.
Southern Illinois University Edwardsville, Residency Teaching Certificate Program: Assessment of Learning. Co-Presented with Carrie Vogler, PharmD, BCPS. Online Course. March 2012, 2013.
Southern Illinois University Edwardsville, Residency Teaching Certificate Program: Teaching/Facilitating Small Groups. Online Course. December 2011, 2012.
National Association for the Dually Diagnosed (NADD) 28th Annual Conference and Exhibit Show: Drug Research Symposium. Pharmacogenomic Biomarkers in Psychotropic Medication Labels. Co-Presented with Robert J. Pary, MD. Nashville, TN. November 2011.
Southern Illinois University Edwardsville, School of Pharmacy Continuing Education Program: Clinical Pearls: Mental Healthcare. Co-presented with Janice Frueh, PharmD, BCPS. Springfield, IL. July 2010.
University at Buffalo Office of Postgraduate Professional Education Continuing Education Program: New and Emerging Therapies in Treatment of Epilepsy. Buffalo, NY. June 2009.
Buffalo Psychiatric Center Educational Seminar Series: What to Do When Your Client Cannot Afford Their Medications. Buffalo, NY. October 2008.
University at Buffalo Department of Pharmacy Practice Seminar: Smoking Cessation Initiatives and Controversies in Adults with Serious Mental Illness. Buffalo, NY. October 2008.
University at Buffalo Office of Postgraduate Professional Education Continuing Education Program: New and Emerging Therapies in Bipolar Disorder. Buffalo, NY. June 2008.
NYS OMH Webinar: Pharmacological Interventions for Treating Tobacco Dependence-Part of the Office of Mental Health LifeSpan Initiative. Co-Presented with Dr. Daryl Sharp, Live webcast throughout New York State, April 2008.
Publications
Pointer S, Gonzalez M. “Latuda®: new dose, new do’s and don’ts?” The Mental Health Clinician, 2012; 2(6).
Gonzalez M, Royce M. Tonic-clonic seizures associated with K2 use: A case report. Journal of Pharmacy Practice. 2012;25(2):300-301.
Gonzalez M, Bishop J. “Understanding pharmacogenomics: clinician resources and references.” The Mental Health Clinician, 2012; 1(9).
Gonzalez M. “Neuropsychiatric pharmacogenomics detailed in prescription package inserts.” The Mental Health Clinician, 2012; 1(9).
Zupancic M, Gonzalez M. “Aripiprazole in the acute and maintenance phase of bipolar I disorder.” Therapeutics and Clinical Risk Management, 2012; 8:1-6.
Gonzalez M. “New drug review- ezogabine (Potiga): seizing the seizure.” The Mental Health Clinician, 2011;1(6).
Gonzalez M. “Viibryd (Vilazodone): viable option or for the byrds?” The Mental Health Clinician, 2011;1(6).
Gonzalez M, Royce M. “Facilitating the continuum of care for patients unable to take oral psychotropic medications: a case report of transdermal venlafaxine.” Journal of Pharmacy Practice, 2011; 24(2): 285.
Bergman S, Ronald K, Gonzalez M, Ruscin JM. Pharmacotherapy Update 2009, Part I: Cardiology, Neurology, and Psychiatry. Annals of Long-Term Care. 2009; 17(12): 30-34.
Bergman S, Ronald K, Gonzalez M, Ruscin JM. Pharmacotherapy Update 2009, Part II: Infectious Disease, Positive Beers Criteria, and Pharmacist Interventions. Annals of Long-Term Care 2010; 18(2): 41-44.
Gonzalez M, Demler T, Bellnier T, Demler T, Bingel S, Simon R. “Cardiometabolic impact of atypical antipsychotics: 10 years later.” Journal of Pharmacy Practice, 2009; 22(2): 208-209.
Cole M, Trigoboff E, Gonzalez M, Bellnier T, Demler T. “Comparison of psychiatric inpatients treated with clozapine and olanzapine: post-smoking cessation.” Journal of Pharmacy Practice, 2009; 22(2): 211.
Gonzalez M, Demler T, Bellnier T. “Clozapine treated psychiatric inpatients post smoking cessation: effect on psychiatric symptomatology.” Journal of Pharmacy Practice, 2008; 21(1).
